Recombinant PSMA (Rosopatamab Biosimilar) antibody
The Humanized Chimeric anti-PSMA (Rosopatamab Biosimilar) antibody has been validated for ELISA and WB. It is suitable to detect PSMA (Rosopatamab Biosimilar) in samples from Human.
Catalog No. ABIN7538085
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant PSMA (Rosopatamab Biosimilar) antibody (ABIN7538085)
Target
PSMA (Rosopatamab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This PSMA (Rosopatamab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Rosopatamab Biosimilar - Anti-FOLH1 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
anti-PSMA (Rosopatamab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Mouse Chimeric unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- PSMA (Rosopatamab Biosimilar)
-
Background
- Rosopatamab (HuJ591) is a humanized anti-PSMA IgG1 monoclonal antibody that can be used in cancer research, especially prostate cancer. Rosopatamab can be linked to the low-energy beta-emitting radioisotope lutetium-177 (177Lu) through the bifunctional chelator DOTA-NHS ester to obtain a radioimmunoconjugate that targets malignant prostate cells with high efficiency.
-
CAS-No
- 2260767-49-3
Target
-
You are here:
